MOULDER LEON O JR (Chief Executive Officer) purchased 15.6% of their position (57K shares) of ZENAS BIOPHARMA, INC. on the open market
Open‑market purchase worth $1.02M — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/3/2026ACC: 0001104659-26-009756
DirectorOfficer· Chief Executive Officer
Since Feb 2026
+57K
Net shares
Net buyer
$1.02M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
57K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+57K
Price / share
$17.96
Trade value
$1.02M
% of position
15.6%
2/2/2026
366.15K→423.15K
Total
Net shares
+57K
Net value
$1.02M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | P · Purchase | +57K | $17.96 | $1.02M | 15.6% | 366.15K | 423.15K |
| Total | +57K | $1.02M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned36.93K
Common Stock
IndirectShares owned1.67M
Total
1.71M indirect1.71M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 36.93K | Indirect |
| Common Stock | 1.67M | Indirect |
| Total | 1.71M | 1.71M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported